These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16750673)

  • 1. Rituximab maintenance therapy in indolent NHL: a clinical review.
    Buske C; Hiddemann W
    Leuk Res; 2006 Mar; 30 Suppl 1():S11-5. PubMed ID: 16750673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
    Vidal L; Gafter-Gvili A; Leibovici L; Dreyling M; Ghielmini M; Hsu Schmitz SF; Cohen A; Shpilberg O
    J Natl Cancer Inst; 2009 Feb; 101(4):248-55. PubMed ID: 19211444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab as maintenance therapy for patients with follicular lymphoma.
    Vidal L; Gafter-Gvili A; Leibovici L; Shpilberg O
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006552. PubMed ID: 19370640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the role of maintenance rituximab in follicular NHL?
    Maloney DG
    Oncology (Williston Park); 2008 Jan; 22(1):20-6; discussion 26, 29, 33-4. PubMed ID: 18251281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonging remission with rituximab maintenance therapy.
    Hainsworth JD
    Semin Oncol; 2004 Feb; 31(1 Suppl 2):17-21. PubMed ID: 15042530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab in indolent lymphomas.
    Sousou T; Friedberg J
    Semin Hematol; 2010 Apr; 47(2):133-42. PubMed ID: 20350660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials.
    Vidal L; Gafter-Gvili A; Salles G; Dreyling MH; Ghielmini M; Hsu Schmitz SF; Pettengell R; Witzens-Harig M; Shpilberg O
    J Natl Cancer Inst; 2011 Dec; 103(23):1799-806. PubMed ID: 22021664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should all patients with indolent lymphoma be treated with rituximab maintenance therapy? An overview of the data.
    Andemariam B; Leonard JP
    Clin Lymphoma Myeloma; 2006 Oct; 7 Suppl 1():S20-3. PubMed ID: 17101069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of rituximab in patients with follicular lymphoma.
    Marcus R
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):38-49. PubMed ID: 17305253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab maintenance in indolent lymphoma: indications and controversies.
    van Oers MH
    Curr Oncol Rep; 2007 Sep; 9(5):378-83. PubMed ID: 17706166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis.
    Vidal L; Gafter-Gvili A; Salles G; Bousseta S; Oberman B; Rubin C; van Oers MH; Fortpied C; Ghielmini M; Pettengell R; Witzens-Harig M; Dreger P; Vitolo U; Gomes da Silva M; Evangelista A; Li H; Freedman L; Habermann TM; Shpilberg O
    Eur J Cancer; 2017 May; 76():216-225. PubMed ID: 28336303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
    Boland A; Bagust A; Hockenhull J; Davis H; Chu P; Dickson R
    Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab maintenance therapy: a step forward in follicular lymphoma.
    van Oers MH
    Haematologica; 2007 Jun; 92(6):826-33. PubMed ID: 17550856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient benefits of maintenance immunotherapy.
    Ghielmini M
    Leuk Res; 2006 Mar; 30 Suppl 1():S22-6. PubMed ID: 16750675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of maintenance therapy.
    Berinstein NL
    Leuk Res; 2006 Mar; 30 Suppl 1():S3-10. PubMed ID: 16750676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of rituximab maintenance therapy in follicular lymphomas.
    Solal-Céligny P
    Leuk Res; 2006 Mar; 30 Suppl 1():S16-21. PubMed ID: 16750674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab maintenance therapy in follicular lymphoma comes of age.
    Hiddemann W
    Leuk Res; 2006 Mar; 30 Suppl 1():S1-2. PubMed ID: 16750672
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of rituximab as maintenance therapy in patients with follicular non-Hodgkin lymphoma after responding to first-line rituximab plus chemotherapy.
    Hornberger J; Chien R; Friedmann M; Han L; Shewade A; Satram-Hoang S; Reyes C
    Leuk Lymphoma; 2012 Dec; 53(12):2371-7. PubMed ID: 22591119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.